Comparison of pain relief between intranasal vs spinal nalbuphine in open inguinal hernia surgeries

A randomized control trial to compare the effectiveness of intra nasal Nalbuphine administration via atomizer vs intrathecal Nalbuphine in patients undergoing open hernia repair - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068471

Enrollment

Registered

2024-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intra nasal Nalbuphine: 0.4mg per kg Nalbuphine via Atomizer intra nasally stat at start of surgery Control Intervention1: Intra thecal Nalbuphine: Intra thecal Nalbuphine 0.5mg along w

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 patients undergoing open inguinal hernia repair surgeries

Exclusion criteria

Exclusion criteria: Patients with known cardiac, renal comorbidities, sinusitis, pregnant patients

Design outcomes

Primary

Measure	Time frame
post operative pain using visual analog scaleTimepoint: At the end of surgery, 1hr and 2 hr after surgery	—

Secondary

Measure	Time frame
Nausea and vomitingTimepoint: Postoperative period;VitalsTimepoint: 2 min, 5 min, 30 min post spinal	—

Countries

India

Contacts

Public ContactBharat Krishna

Saveetha Medical College

bharatvmch2015@gmail.com9500265345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026